Sign Up Today and Learn More About Innovaccer Stock
Invest in or calculate the value of your shares in Innovaccer or other pre-IPO companies through EquityZen's platform.
Innovaccer Stock (INNA)
Healthcare Data Analytics Platform
Innovaccer is a healthcare data activation platform company.
About Innovaccer Stock
Founded
2014
Headquarters
San Francisco, CA, US
Total Funding
818M
Industries
Software, Data and Analytics, Science and Engineering
Innovaccer is a healthcare data activation platform company. Innvoaccer aims to simplify complex data from all points of care, streamline the information, and help organizations make powerful decisions and realize strategic goals based on key insights and predictions from their data.Â
Innovaccer was founded in 2014 by Abhinav Shashank, Kanav Hasija, and Sandeep Gupta and is headquartered in San Francisco with offices around the United States and Asia. Notable investors include Sequoia Capital India, Westbridge Capital, M12 - Microsoft's Venture Fund, and Tiger Global Management.
Innovaccer Press Mentions
Stay in the know about the latest news on Innovaccer
CareQuest Institute Partners with Innovaccer to Improve Medical-Dental Data Integration
businesswire • Feb 17, 2026
CareQuest Institute Partners with Innovaccer to Improve Medical-Dental Data Integration
morningstar • Feb 17, 2026
Innovaccer Achieves Best in KLAS Across Data & AI Platform for Providers, Payer AI, and CRM
businesswire • Feb 04, 2026
Embedding clinical intelligence to help close care gaps
healthcareitnews • Jan 31, 2026
AI Leader Smriti Kirubanandan Joins Innovaccer as Managing Director to Scale Gravity Platform
prweb • Jan 30, 2026
Investors in Innovaccer
Discover investors in Innovaccer stock and explore their portfolio companies
Innovaccer Management
Leadership team at Innovaccer
Chief Executive Officer
Abhinav Shashank
Chief Financial Officer
Scott Bruckner
Join now and verify your accreditation status to gain access to:
- Innovaccer Current Valuation
- Innovaccer Stock Price
- Innovaccer Management
- Available deals in Innovaccer and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Innovaccer Cap Table and Funding History by Share Class and Liquidity Preferences
- Innovaccer Revenue and Financials
- Innovaccer Highlights
- Innovaccer Business Model
- Innovaccer Risk Factors
- Innovaccer Research Report from SACRA Research
Innovaccer Key Facts
- Securing Significant Funding and Strategic Partnerships: Innovaccer closed a $275 million Series F funding round in January 2025. The round included new strategic investors such as Kaiser Permanente, Banner Health, and Danaher Diagnostics. This capital infusion, along with a total funding of $675 million, and these partnerships with major healthcare players, demonstrate strong market confidence and a clear path to integrating Innovaccer's technology into large health systems.
- Top-Tier Industry Recognition for AI and CRM: Innovaccer has been recognized as the 2025 Best in KLAS CRM Solution for the second consecutive year, earning a score of 94.5 out of 100. Its Risk Analytics solution also received high marks in the same report. This recognition, which is based on feedback from thousands of providers, highlights the company's strong brand reputation and its ability to deliver high-quality, effective, and AI-powered solutions that meet the specific needs of healthcare professionals.
- Launch of New AI-Powered Solutions and Platforms: The company is aggressively expanding its product suite with new AI-powered tools. In May 2025, Innovaccer launched "Innovaccer Gravity™," a cloud-agnostic healthcare intelligence platform to accelerate AI adoption. The company also acquired Humbi AI in January 2025 to launch actuarial copilots, and introduced new AI-powered solutions for readmissions management and pharmacy quality solutions, demonstrating a commitment to continuous innovation and market leadership in healthcare AI.
- Implementation and Cost Hurdles: While Innovaccer is a leader in its space, the company's own content highlights the challenges of implementing risk adjustment software for healthcare organizations. These hurdles include high upfront costs, extensive staff training, and potential productivity losses during the transition. For smaller practices or those with tight budgets, justifying this investment can be difficult, which represents a barrier to entry and a risk to capturing the full market.
- Complexity and Interoperability Challenges: The healthcare technology sector is burdened by siloed and fragmented data from disparate systems. Innovaccer's platform is designed to solve this, but its effectiveness depends on the quality of the data it receives. A company-published report from 2024 notes that a lack of data readiness and interoperability among its customers threatens their digital transformation plans. This complexity poses a risk to Innovaccer's operational performance, as it must continually manage data flow issues and ensure seamless integration across a diverse range of client systems.
- Intense Competition from Multiple Angles: The healthcare technology market is becoming increasingly crowded with both new players and well-funded tech giants. Innovaccer faces competition from a variety of companies offering AI and data solutions. The push for new AI-powered tools and an emphasis on "whole-person care" is attracting a wide range of companies that could challenge Innovaccer's market position.
Trading Innovaccer Stock
How to invest in Innovaccer stock?
Accredited investors can buy pre-IPO stock in companies like Innovaccer through EquityZen funds. These investments are made available by existing Innovaccer shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Innovaccer stock?
Shareholders can sell their Innovaccer stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
